Loading...
Liquidia Corporation
LQDA•NASDAQ
Healthcare
Biotechnology
$24.10
$0.00(0.00%)
Liquidia Corporation (LQDA) Company Profile & Overview
Explore Liquidia Corporation’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Liquidia Corporation (LQDA) Company Profile & Overview
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil injection in the United States. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
SectorHealthcare
IndustryBiotechnology
CEORoger A. Jeffs
Contact Information
Company Facts
170 Employees
IPO DateJul 26, 2018
CountryUS
Actively Trading